A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury
Authors
Keywords
Traumatic brain injury, Neuroinflammation, NLRP3, Inflammasome, Cytokines
Journal
Journal of Neuroinflammation
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-11
DOI
10.1186/s12974-019-1471-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury
- (2018) Xintong Ge et al. BRAIN RESEARCH
- Inflammasome: Its role in traumatic brain and spinal cord injury
- (2018) Keywan Mortezaee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
- (2018) Jacob Fulp et al. JOURNAL OF MEDICINAL CHEMISTRY
- MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
- (2018) Saifudeen Ismael et al. JOURNAL OF NEUROTRAUMA
- Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury
- (2018) Xin Xu et al. NEUROBIOLOGY OF DISEASE
- Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke
- (2018) Saifudeen Ismael et al. Scientific Reports
- Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury
- (2017) Chao Lin et al. EXPERIMENTAL NEUROLOGY
- Sexual dimorphism in the inflammatory response to traumatic brain injury
- (2017) Sonia Villapol et al. GLIA
- NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
- (2017) Jun Yin et al. MOLECULAR NEUROBIOLOGY
- The far-reaching scope of neuroinflammation after traumatic brain injury
- (2017) Dennis W. Simon et al. Nature Reviews Neurology
- Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children
- (2017) Jessica S. Wallisch et al. Neurocritical Care
- Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage
- (2017) Honglei Ren et al. STROKE
- Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury
- (2017) Natasha Irrera et al. Frontiers in Pharmacology
- Microglia in the TBI brain: The good, the bad, and the dysregulated
- (2016) David J. Loane et al. EXPERIMENTAL NEUROLOGY
- Propofol Inhibits NLRP3 Inflammasome and Attenuates Blast-Induced Traumatic Brain Injury in Rats
- (2016) Jie Ma et al. INFLAMMATION
- Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype
- (2016) Antonella Tramutola et al. JOURNAL OF ALZHEIMERS DISEASE
- Nonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury
- (2016) Thomas Brickler et al. MEDIATORS OF INFLAMMATION
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- Emerging Roles for the Immune System in Traumatic Brain Injury
- (2016) Celia A. McKee et al. Frontiers in Immunology
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inhibiting the Inflammasome: A Chemical Perspective
- (2015) Alex G. Baldwin et al. JOURNAL OF MEDICINAL CHEMISTRY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Caspase-1: an integral regulator of innate immunity
- (2015) Stefan Winkler et al. Seminars in Immunopathology
- ER stress induces NLRP3 inflammasome activation and hepatocyte death
- (2015) C Lebeaupin et al. Cell Death & Disease
- Pyroptotic Neuronal Cell Death Mediated by the AIM2 Inflammasome
- (2014) Stephanie E Adamczak et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inflammasomes in the CNS
- (2014) John G. Walsh et al. NATURE REVIEWS NEUROSCIENCE
- AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
- (2013) V Sagulenko et al. CELL DEATH AND DIFFERENTIATION
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation
- (2013) M. E. Heid et al. JOURNAL OF IMMUNOLOGY
- The NLRP3 Inflammasome in Alzheimer’s Disease
- (2013) Meng-Shan Tan et al. MOLECULAR NEUROBIOLOGY
- Expression of the NLRP3 Inflammasome in Cerebral Cortex After Traumatic Brain Injury in a Rat Model
- (2013) Huan-Dong Liu et al. NEUROCHEMICAL RESEARCH
- The Role of Markers of Inflammation in Traumatic Brain Injury
- (2013) Thomas Woodcock et al. Frontiers in Neurology
- Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome
- (2012) Stephanie Adamczak et al. JOURNAL OF NEUROSURGERY
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
- (2012) Michael T. Heneka et al. NATURE
- The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
- (2012) Geun-Shik Lee et al. NATURE
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NLRP3 Inflammasome Contributes to Brain Injury in Pneumococcal Meningitis and Is Activated through ATP-Dependent Lysosomal Cathepsin B Release
- (2011) Tobias Hoegen et al. JOURNAL OF IMMUNOLOGY
- Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia
- (2011) Richa Hanamsagar et al. JOURNAL OF NEUROCHEMISTRY
- Sustained Survival and Maturation of Adult Neural Stem/Progenitor Cells after Transplantation into the Injured Brain
- (2011) Dong Sun et al. JOURNAL OF NEUROTRAUMA
- Interleukin 18 in the CNS
- (2010) Silvia Alboni et al. Journal of Neuroinflammation
- The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18
- (2010) S. Jha et al. JOURNAL OF NEUROSCIENCE
- Strain-Related Differences after Experimental Traumatic Brain Injury in Rats
- (2010) Wendy Murdock Reid et al. JOURNAL OF NEUROTRAUMA
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Neutralization of interleukin-1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice
- (2009) Fredrik Clausen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury
- (2009) Juan Pablo de Rivero Vaccari et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The NALP3 inflammasome is involved in the innate immune response to amyloid-β
- (2008) Annett Halle et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More